MYSTERIOUS: 8 - You Need To See This

Medicare's New $50 GLP-1 Weight-Loss Program Just Launched: Find Out if You Qualify

Medicare's GLP-1 Bridge launched July 1, 2026. Up to 3.8M seniors may qualify for $50/month Wegovy, Zepbound, or Foundayo. Here's the eligibility breakdown.

Medical Daily · Jul 2

Obese adults heart attack risk now similar to slim people thanks to widespread use of statins, study finds

Statins, a cholesterol lowering drug taken by about 8 million people in the UK, could be narrowing the heart attack risk between obese adults and those of a healthy weight

The Independent UK · Jul 2

Four GLP-1 Findings from June 2026 Are Changing the Picture of What These Drugs Actually Do

Four GLP-1 studies published in June 2026 show effects on breast cancer, violence, bone fractures, and physical activity. Here's what each found and what it means for patients.

Medical Daily · Jun 30

'Cheaper than a gym, but still not selling': Nithin Kamath on why Indians aren't embracing popular weight-loss drugs

Despite rising obesity and affordable generic GLP-1 drugs, India lags in adoption. Nithin Kamath highlights patient retention challenges with weekly injections and conservative doctor prescribing habits as key hurdles. The advent of oral alternatives might boost uptake, suggesting convenience and long-term commitment, rather than price, will drive future acceptance of…

The Economic Times · Jun 26

White House denies Donald Trump is the mystery patient receiving experimental obesity drug: ‘Idiotic question’

White House spokesperson says gossip that Trump is the patient is "baseless speculation."

We Got This Covered · Jun 25

Did Trump Get Experimental Obesity Drug? Rep Lieu Demands Answers Over FDA's 'Powerful Drug' Given to 'Unidentified 79-Year-Old Man'

Representative Ted Lieu questions the White House about claims that President Trump accessed an experimental obesity drug reserved for the gravely ill, sparking controversy and speculation.

International Business Times UK · Jun 25

Medicare's New $50 Weight Loss Drug Program Starts July 1 — but the Fine Print Could Surprise You

Medicare's GLP-1 Bridge starts July 1, 2026, with $50/month copays. But there are major fine-print limitations seniors need to know before signing up. Here's what to check.

Medical Daily · Jun 25

Trump Linked to Mystery FDA Deal Granting Early Access to Powerful Weight-Loss Drug for Critical Patients

A 79-year-old patient received early access to Eli Lilly's experimental obesity drug retatrutide, sparking political and medical controversy amid speculation about the patient's identity.

International Business Times UK · Jun 24

White House denies Trump is the ‘well-connected’ man who gained compassionate access to obesity drug in April

A White House spokesman said theories that President Trump sought the drug were ‘baseless speculation’

The Independent UK · Jun 23

As Aussie waistlines expand, so do treatment costs

Most adult Australians are actually overweight or obese and that number is rising, research shows, with the problem taking a growing toll on health systems.

AAP · Jun 23